Biomedico Hadarim Ltd
Augwind Energy Tech, a technology company, offers compression, expansion, and storage solutions for energy storage and energy efficiency applications in Israel. The company offers AirBattery, an energy storage system that is a combination of pumped hydro and compressed air energy storage to enable grid-scale energy storage; water compressors; AirSmart, an energy efficiency solution for air compre… Read more
Biomedico Hadarim Ltd (ITGMF) - Total Assets
Latest total assets as of June 2025: $62.08 Million USD
Based on the latest financial reports, Biomedico Hadarim Ltd (ITGMF) holds total assets worth $62.08 Million USD as of June 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Biomedico Hadarim Ltd - Total Assets Trend (2018–2024)
This chart illustrates how Biomedico Hadarim Ltd’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Biomedico Hadarim Ltd - Asset Composition Analysis
Current Asset Composition (December 2024)
Biomedico Hadarim Ltd's total assets of $62.08 Million consist of 82.8% current assets and 17.2% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 25.4% |
| Accounts Receivable | $2.96 Million | 4.3% |
| Inventory | $1.50 Million | 2.2% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $278.00K | 0.4% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2018–2024)
This chart illustrates how Biomedico Hadarim Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Biomedico Hadarim Ltd's current assets represent 82.8% of total assets in 2024, an increase from 0.0% in 2018.
- Cash Position: Cash and equivalents constituted 25.4% of total assets in 2024, up from 0.0% in 2018.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2018.
- Asset Diversification: The largest asset category is accounts receivable at 4.3% of total assets.
Biomedico Hadarim Ltd Competitors by Total Assets
Key competitors of Biomedico Hadarim Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Hanil Vacuum Co. Ltd
KQ:123840
|
Korea | ₩115.98 Billion |
|
Ivisionworks Co.,Ltd.
KQ:469750
|
Korea | ₩50.10 Billion |
|
Huayi Compressor Co Ltd
SHE:000404
|
China | CN¥15.16 Billion |
|
Shenyang Machine Tool Co Ltd
SHE:000410
|
China | CN¥9.63 Billion |
|
North Industries Group Red Arrow Co Ltd
SHE:000519
|
China | CN¥17.38 Billion |
|
Changchai Co Ltd
SHE:000570
|
China | CN¥5.30 Billion |
|
Jiangsu Youli Investment Holding Co Ltd
SHE:000584
|
China | CN¥3.49 Billion |
|
Baota Industry Co Ltd
SHE:000595
|
China | CN¥9.54 Billion |
Biomedico Hadarim Ltd - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Biomedico Hadarim Ltd generates 0.20x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Biomedico Hadarim Ltd is currently not profitable relative to its asset base.
Biomedico Hadarim Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 5.27 | 7.06 | 10.02 |
| Quick Ratio | 5.24 | 6.79 | 9.90 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $40.67 Million | $ 53.08 Million | $ 131.10 Million |
Biomedico Hadarim Ltd - Advanced Valuation Insights
This section examines the relationship between Biomedico Hadarim Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.67 |
| Latest Market Cap to Assets Ratio | 0.08 |
| Asset Growth Rate (YoY) | -8.4% |
| Total Assets | $68.98 Million |
| Market Capitalization | $5.27 Million USD |
Valuation Analysis
Below Book Valuation: The market values Biomedico Hadarim Ltd's assets below their book value (0.08 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Biomedico Hadarim Ltd's assets decreased by 8.4% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Biomedico Hadarim Ltd (2018–2024)
The table below shows the annual total assets of Biomedico Hadarim Ltd from 2018 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $68.98 Million | -8.43% |
| 2023-12-31 | $75.33 Million | -34.77% |
| 2022-12-31 | $115.48 Million | -38.26% |
| 2021-12-31 | $187.06 Million | -1.75% |
| 2020-12-31 | $190.40 Million | +1336.62% |
| 2019-12-31 | $13.25 Million | -- |
| 2018-12-31 | $0.00 | -- |